331 related articles for article (PubMed ID: 35348938)
1. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements.
Dammacco F; Lauletta G; Vacca A
Clin Exp Med; 2023 Jun; 23(2):255-272. PubMed ID: 35348938
[TBL] [Abstract][Full Text] [Related]
2. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.
Dammacco F; Lauletta G; Russi S; Leone P; Tucci M; Manno C; Monaco S; Ferrari S; Vacca A; Racanelli V
Clin Exp Med; 2019 Feb; 19(1):1-21. PubMed ID: 30430284
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus-related cryoglobulinemic vasculitis.
Mazzaro C; Mauro E; Ermacora A; Doretto P; Fumagalli S; Tonizzo M; Toffolutti F; Gattei V
Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
[TBL] [Abstract][Full Text] [Related]
4. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study.
Chang ML; Cheng JS; Chuang YH; Pao LH; Wu TS; Chen SC; Chang MY; Chien RN
Front Immunol; 2022; 13():823160. PubMed ID: 35371039
[TBL] [Abstract][Full Text] [Related]
5. The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.
Roccatello D; Sciascia S; Rossi D; Solfietti L; Fenoglio R; Menegatti E; Baldovino S
Oncotarget; 2017 Jun; 8(25):41764-41777. PubMed ID: 28454112
[TBL] [Abstract][Full Text] [Related]
6. Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).
Quartuccio L; Bortoluzzi A; Scirè CA; Marangoni A; Del Frate G; Treppo E; Castelnovo L; Saccardo F; Zani R; Candela M; Fraticelli P; Mazzaro C; Renoldi P; Scaini P; Filippini DA; Visentini M; Scarpato S; Giuggioli D; Mascia MT; Sebastiani M; Zignego AL; Lauletta G; Fiorilli M; Casato M; Ferri C; Pietrogrande M; Pioltelli PE; De Vita S; Monti G; Galli M
Clin Rheumatol; 2023 Feb; 42(2):359-370. PubMed ID: 36169798
[TBL] [Abstract][Full Text] [Related]
7. Understanding the Cryoglobulinemias.
Fuentes A; Mardones C; Burgos PI
Curr Rheumatol Rep; 2019 Nov; 21(11):60. PubMed ID: 31741077
[TBL] [Abstract][Full Text] [Related]
8. Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis.
Gragnani L; Lorini S; Martini L; Stasi C; Visentini M; Petraccia L; Marello N; Monti M; Marri S; Madia F; Ricca V; Zignego AL
Clin Rheumatol; 2022 Jan; 41(1):147-157. PubMed ID: 34409558
[TBL] [Abstract][Full Text] [Related]
9. The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.
Dammacco F; Racanelli V; Russi S; Sansonno D
Clin Exp Med; 2016 Aug; 16(3):233-42. PubMed ID: 26935415
[TBL] [Abstract][Full Text] [Related]
10. Impact of direct acting antivirals on hepatitis C virus-related cryoglobulinemic syndrome.
Zignego AL; Marri S; Gragnani L
Minerva Gastroenterol (Torino); 2021 Sep; 67(3):218-226. PubMed ID: 33793154
[TBL] [Abstract][Full Text] [Related]
11. Cryoglobulinemic vasculitis: a 2023 update.
Moretti M; Ferro F; Baldini C; Mosca M; Talarico R
Curr Opin Rheumatol; 2024 Jan; 36(1):27-34. PubMed ID: 37916482
[TBL] [Abstract][Full Text] [Related]
12. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.
Giuggioli D; Manfredi A; Colaci M; Manzini CU; Antonelli A; Ferri C
Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565
[TBL] [Abstract][Full Text] [Related]
13. New insights in cryoglobulinemic vasculitis.
Silva F; Pinto C; Barbosa A; Borges T; Dias C; Almeida J
J Autoimmun; 2019 Dec; 105():102313. PubMed ID: 31383568
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.
Bonacci M; Lens S; Mariño Z; Londoño MC; Rodriguez-Tajes S; Sánchez-Tapias JM; Ramos-Casals M; Hernández-Rodríguez J; Forns X
Gastroenterology; 2018 Aug; 155(2):311-315.e6. PubMed ID: 29705529
[TBL] [Abstract][Full Text] [Related]
15. The dilemma of treating hepatitis C virus-associated cryoglobulinemia.
Roccatello D; Fenoglio R; Sciascia S
Curr Opin Rheumatol; 2019 Sep; 31(5):499-504. PubMed ID: 31090590
[TBL] [Abstract][Full Text] [Related]
16. Rheumatologic manifestations of Hepatitis C Virus.
Treppo E; Quartuccio L; Ragab G; DE Vita S
Minerva Med; 2021 Apr; 112(2):201-214. PubMed ID: 33263372
[TBL] [Abstract][Full Text] [Related]
17. Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.
Montero N; Favà A; Rodriguez E; Barrios C; Cruzado JM; Pascual J; Soler MJ
Cochrane Database Syst Rev; 2018 May; 5(5):CD011403. PubMed ID: 29734473
[TBL] [Abstract][Full Text] [Related]
18. Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease.
Argyropoulou OD; Pezoulas V; Chatzis L; Critselis E; Gandolfo S; Ferro F; Quartuccio L; Donati V; Treppo E; Bassoli CR; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos TE; Mavragani CP; Baldini C; Skopouli FN; Galli M; Fotiadis DΙ; De Vita S; Moutsopoulos HM; Tzioufas AG; Goules AV
Semin Arthritis Rheum; 2020 Oct; 50(5):846-853. PubMed ID: 32896698
[TBL] [Abstract][Full Text] [Related]
19. Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals.
Bonacci M; Lens S; Londoño MC; Mariño Z; Cid MC; Ramos-Casals M; Sánchez-Tapias JM; Forns X; Hernández-Rodríguez J
Clin Gastroenterol Hepatol; 2017 Apr; 15(4):575-583.e1. PubMed ID: 27725289
[TBL] [Abstract][Full Text] [Related]
20. Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life.
Gragnani L; Lorini S; Marri S; Vacchi C; Madia F; Monti M; Ferri C; Zignego AL
Autoimmun Rev; 2022 Jan; 21(1):102923. PubMed ID: 34419670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
